Cash
Portfolio
TrendingMidtermsElectionsPoliticsSportsCultureCryptoCommoditiesClimateEconomicsMentionsFinanceTech & Science
PredictLive129AccountSocial
MARKETSINVESTLIVE129
Product
Kalshi ProInvestMarketsIncentive programSmall business hedgingInstitutionsAPI & developers
Company
AboutKalshi ResearchBlogCareersPolicy CenterBrand Kit
Help
Help CenterFAQFee scheduleTrading hoursRegulatoryTrust Center
© 2026 Kalshi Inc. · All rights reserved
PrivacyData Terms of ServiceTrading ProhibitionsFAQ for Finance Professionals
Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.
Series Image
  1. Medicine

When will Compass Pathways submit a NDA for COMP360 psilocybin?

Chance
before December
94%
▲ 4

before December

94%
▲ 4
before 2027
89%

before 2027

89%
before April 2027
99%

before April 2027

99%
3 more
When will Compass Pathways submit a NDA for COMP360 psilocybin?

before December

Odds
97% chance
Max payout
Dec 1, 2026
$0
$33,425 vol
More Science and Technology Markets

Trending Science and Technology markets

Will the U.S. confirm that aliens exist?Best AI at the end of 2026?Open vs. Closed Token Volume (open weights share) in Nov 7, 2026OpenRouter token usage in Nov 2–8, 2026When will OpenAI release Astra 6.1+?Anthropic market share this weekOpenAI market share this weekWhen will any company achieve AGI?

Science and Technology hub

All Science and Technology markets